We are live on
!
Find out more
CT
Cambridge Trust Portfolio holdings
AUM
$2.64B
Turnover
15.41%
1-Year Est. Return
28.73%
This Fund
S&P 500
This Quarter
Est. Return
-13.22%
1 Year Est. Return
+28.73%
3 Year Est. Return
+42.93%
5 Year Est. Return
+123.28%
10 Year Est. Return
+319.24%
AUM
$2.28B
AUM Growth
-$571M
(-20%)
Cap. Flow
-$160M
Cap. Flow
% of AUM
-7.02%
Top 10 Holdings %
Top 10 Hldgs %
27.44%
Holding
985
New
54
Increased
140
Reduced
331
Closed
122
Avg Time Held
1.9
years
Top 10 Avg Time Held
2.6
years
Top 20 Avg Time Held
3.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$13.7M |
| 2 |
Coca-Cola
KO
|
+$10.7M |
| 3 |
CVS Health
CVS
|
+$9.84M |
| 4 |
Chart Industries
GTLS
|
+$4.3M |
| 5 |
Eaton
ETN
|
+$4.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$45.1M |
| 2 |
Apple
AAPL
|
+$17.6M |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
+$15.8M |
| 4 |
Danaher
DHR
|
+$12.1M |
| 5 |
Meta Platforms (Facebook)
META
|
+$11M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.07% |
| 2 | Financials | 16.12% |
| 3 | Healthcare | 14.36% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Miscellaneous | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
626
HNI Corp
HNI
$3.38B
| $17K | ﹤0.01% |
500
| – | – |
2021 Q4
2 quarters
|
|
627
Magnite
MGNI
$3.35B
| $17K | ﹤0.01% |
1,900
| – | – |
2021 Q4
2 quarters
|
|
628
Northwest Natural Holdings
NWN
$2.06B
| $17K | ﹤0.01% |
323
| – | – |
2021 Q4
2 quarters
|
|
629
Expeditors International
EXPD
$25.5B
| $16K | ﹤0.01% |
165
-97
| -37% | -$9.94K |
2021 Q4
2 quarters
|
|
630
Rogers Communications
RCI
$17.3B
| $16K | ﹤0.01% |
+325
| New | +$17K |
2022 Q2
0 quarters
|
|
631
Valero Energy
VLO
$128B
| $16K | ﹤0.01% |
150
| – | – |
2021 Q4
2 quarters
|
|
632
DELISTED
CATALENT, INC.
CTLT
| $16K | ﹤0.01% |
152
-425
| -74% | -$43.3K |
2021 Q4
2 quarters
|
|
633
Ulta Beauty
ULTA
$25.4B
| $15K | ﹤0.01% |
39
-50
| -56% | -$19.9K |
2021 Q4
2 quarters
|
|
634
Vodafone
VOD
$37.3B
| $15K | ﹤0.01% |
979
-23
| -2% | -$367 |
2021 Q4
2 quarters
|
|
635
DELISTED
Splunk Inc
SPLK
| $15K | ﹤0.01% |
167
| – | – |
2021 Q4
2 quarters
|
|
636
Abeona Therapeutics
ABEO
$253M
| $14K | ﹤0.01% |
2,617
| – | – |
2015 Q2
28 quarters
|
|
637
Arbutus Biopharma
ABUS
$836M
| $14K | ﹤0.01% |
5,000
| – | – |
2021 Q4
2 quarters
|
|
638
Akamai
AKAM
$12.6B
| $14K | ﹤0.01% |
150
-28
| -16% | -$2.92K |
2021 Q4
2 quarters
|
|
639
Ares Capital
ARCC
$13.4B
| $14K | ﹤0.01% |
788
| – | – |
2021 Q4
2 quarters
|
|
640
Ares Management
ARES
$25.5B
| $14K | ﹤0.01% |
250
| – | – |
2021 Q4
2 quarters
|
|
641
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.68B
| $14K | ﹤0.01% |
+1,539
| New | +$14.4K |
2022 Q2
0 quarters
|
|
642
Brookfield Renewable
BEP
$8.52B
| $14K | ﹤0.01% |
+402
| New | +$14.5K |
2022 Q2
0 quarters
|
|
643
Chemours
CC
$1.92B
| $14K | ﹤0.01% |
452
| – | – |
2021 Q4
2 quarters
|
|
644
Ciena
CIEN
$47.2B
| $14K | ﹤0.01% |
300
| – | – |
2021 Q4
2 quarters
|
|
645
F5
FFIV
$25B
| $14K | ﹤0.01% |
+93
| New | +$16.2K |
2022 Q2
0 quarters
|
|
646
Fortinet
FTNT
$124B
| $14K | ﹤0.01% |
250
| – | – |
2021 Q4
2 quarters
|
|
647
KKR & Co
KKR
$77.4B
| $14K | ﹤0.01% |
300
-410
| -58% | -$21.5K |
2021 Q4
2 quarters
|
|
648
SAP
SAP
$259B
| $14K | ﹤0.01% |
155
-60
| -28% | -$5.99K |
2021 Q4
2 quarters
|
|
649
Agnico Eagle Mines
AEM
$96B
| $13K | ﹤0.01% |
275
| – | – |
2021 Q4
2 quarters
|
|
650
Alcon
ALC
$32B
| $13K | ﹤0.01% |
180
+157
| +683% | +$11.5K |
2021 Q4
2 quarters
|
|
Similar funds
ZCM
CQS
SCM
AFIMH
DA
Cambridge Trust's Q2 2022 Portfolio in Review
As of Q2 2022, Cambridge Trust held 985 positions worth $2.28B, down 20% from $2.86B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Cambridge Trust withdrew a net $160M in Q2 2022, closing 122 positions and reducing 331 holdings. Its most notable exit was Paycom, an estimated $915K position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Cambridge Trust opened a new position in Chart Industries worth $4.21M.
- Cambridge Trust's largest Q2 2022 buy was Chart Industries: 25,166 shares worth $4.21M.
- Cambridge Trust added most to ExxonMobil in Q2 2022, an estimated $13.7M increase.
- Cambridge Trust's biggest Q2 2022 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $45.1M.
- Cambridge Trust fully exited Paycom in Q2 2022, selling an estimated $915K.
- Cambridge Trust's ten largest holdings make up 27% of its $2.28B portfolio in Q2 2022.
- Cambridge Trust opened 54 new positions and closed 122 in Q2 2022.
- Cambridge Trust's portfolio value fell 20% quarter-over-quarter to $2.28B.
Based on Cambridge Trust's 13F filing for Q2 2022, filed 16 Aug 2022.